Data Portal @ linkeddatafragments.org

Matches in Harvard for { <http://id.lib.harvard.edu/aleph/004897714/catalog> ?p ?o. }

• catalog abstract "Prozac. Millions of Americans are on it. And just about everyone else is wondering if they should be on it, too. The claims of the pro-Prozac chorus are enticing: that it can cure everything from depression (the only disorder for which Prozac was originally approved) to fear of public speaking, PMS, obesity, shyness, migraine, and back pain - with few or no side effects. But is the reality quite different? At what price do we buy Prozac-induced euphoria and a shiny new personality? Psychiatrist Peter Breggin, M.D., and coauthor Ginger Ross Breggin answer these and other crucial questions in Talking Back to Prozac. They explain what Prozac is and how it works. And they take a hard look at the real story behind today's most controversial drug: the fact that Prozac was tested in trials of four to six weeks in length before receiving FDA approval; the difficulty Prozac's manufacturer had in proving its effectiveness during these tests; the information on side effects that the FDA failed to include in its final labeling requirements; how Prozac acts as a stimulant not unlike the addictive drugs cocaine and amphetamine; the dangers of possible Prozac addiction and abuse; the seriousness and frequency of Prozac's side effects, including agitation, insomnia, nausea, diarrhea, loss of libido, and difficulty reaching orgasm; the growing evidence that Prozac can cause violence and suicide; and the social and workplace implications of using the drug not to cure depression but to change personality and enhance performance. Using dramatic case histories as well as scientific research and carefully documented evidence, the Breggins expose the potentially damaging effects of Prozac. They also describe the resounding success that has been achieved with more humane alternatives for the treatment of depression. Talking Back to Prozac provides essential information for anyone who takes Prozac or is considering taking it, and for those who prescribe it.".
• catalog contributor b6925850.
• catalog contributor b6925851.
• catalog created "1994.".
• catalog date "1994".
• catalog date "1994.".
• catalog dateCopyrighted "1994.".
• catalog description "And they take a hard look at the real story behind today's most controversial drug: the fact that Prozac was tested in trials of four to six weeks in length before receiving FDA approval; the difficulty Prozac's manufacturer had in proving its effectiveness during these tests; the information on side effects that the FDA failed to include in its final labeling requirements; how Prozac acts as a stimulant not unlike the addictive drugs cocaine and amphetamine; the dangers of possible Prozac addiction and abuse; the seriousness and frequency of Prozac's side effects, including agitation, insomnia, nausea, diarrhea, loss of libido, and difficulty reaching orgasm; the growing evidence that Prozac can cause violence and suicide; and the social and workplace implications of using the drug not to cure depression but to change personality and enhance performance.".
• catalog description "Includes bibliographical references (p. [241]-263) and index.".
• catalog description "Prozac. Millions of Americans are on it. And just about everyone else is wondering if they should be on it, too. The claims of the pro-Prozac chorus are enticing: that it can cure everything from depression (the only disorder for which Prozac was originally approved) to fear of public speaking, PMS, obesity, shyness, migraine, and back pain - with few or no side effects. But is the reality quite different? At what price do we buy Prozac-induced euphoria and a shiny new personality?".
• catalog description "Psychiatrist Peter Breggin, M.D., and coauthor Ginger Ross Breggin answer these and other crucial questions in Talking Back to Prozac. They explain what Prozac is and how it works.".
• catalog description "Should we listen to Prozac? -- A primer on how Prozac is supposed to work -- The real story behind Prozac's approval by the FDA -- The real story behind Prozac's side effects -- Drug addiction and abuse: a comparison between Prozac and amphetamines -- Drug-induced paranoia, violence, depression, and suicide: a comparison between Prozac and amphetamines -- Can Prozac cause violence and suicide? what survivors, independent researchers, and the FDA have to say -- Pushing drugs in America: the long financial tentacles of Eli Lilly -- How and why to stop taking psychiatric drugs -- Understanding and overcoming depression.".
• catalog description "Using dramatic case histories as well as scientific research and carefully documented evidence, the Breggins expose the potentially damaging effects of Prozac. They also describe the resounding success that has been achieved with more humane alternatives for the treatment of depression. Talking Back to Prozac provides essential information for anyone who takes Prozac or is considering taking it, and for those who prescribe it.".
• catalog extent "xiv, 273 p. :".
• catalog identifier "0312114869".
• catalog issued "1994".
• catalog issued "1994.".
• catalog language "eng".
• catalog publisher "New York : St. Martin's Press,".
• catalog subject "615/.78 20".
• catalog subject "Antipsychiatry.".
• catalog subject "Fluoxetine Moral and ethical aspects.".
• catalog subject "Fluoxetine Side effects.".
• catalog subject "Fluoxetine Social aspects.".
• catalog subject "Fluoxetine adverse effects.".
• catalog subject "Personality Disorders chemically induced.".
• catalog subject "Personality change.".
• catalog subject "QV 77.5 B833 1994".
• catalog subject "RC483.5.F55 B75 1994".
• catalog tableOfContents "Should we listen to Prozac? -- A primer on how Prozac is supposed to work -- The real story behind Prozac's approval by the FDA -- The real story behind Prozac's side effects -- Drug addiction and abuse: a comparison between Prozac and amphetamines -- Drug-induced paranoia, violence, depression, and suicide: a comparison between Prozac and amphetamines -- Can Prozac cause violence and suicide? what survivors, independent researchers, and the FDA have to say -- Pushing drugs in America: the long financial tentacles of Eli Lilly -- How and why to stop taking psychiatric drugs -- Understanding and overcoming depression.".
• catalog title "Talking back to Prozac : what doctors won't tell you about today's most controversial drug / Peter R. Breggin and Ginger Ross Breggin.".
• catalog type "text".